Medicover AB
OTC:MCVEY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medicover AB
OTC:MCVEY
|
SE |
|
A
|
ASM International NV
XMUN:AVS
|
NL |
|
N
|
Nine Dragons Paper (Holdings) Ltd
XMUN:N3Y
|
HK |
|
C
|
CoStar Group Inc
XMUN:RLG
|
US |
|
O
|
Oxford Industries Inc
XBER:OXD
|
US |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
E
|
Epizyme Inc
F:EPE
|
US |
|
IG Design Group PLC
F:LYG
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MCVEY's stock price target?
Not Available
MCVEY does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Medicover AB?
Projected CAGR
12%
Over the last 9 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Medicover AB?
Projected CAGR
18%
Over the last 9 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 8 years is 18%.
What is the Net Income forecast for Medicover AB?
Projected CAGR
30%
Over the last 9 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 3 years is 30%.
